MEDP
Get informed when a big investor buys or sells
+ FollowUndervalued by 11.7% based on the discounted cash flow analysis.
| Market cap | $16.49 Billion |
|---|---|
| Enterprise Value | $17.01 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $15.64 |
| Beta | 1.15 |
| Outstanding Shares | 28,308,000 |
| P/E Ratio | 33.97 |
|---|---|
| PEG | 98.57 |
| Price to Sales | 5.94 |
| Price to Book Ratio | 38.8 |
| Enterprise Value to Revenue | 6.11 |
| Enterprise Value to EBIT | 29.23 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 2.36 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 10.0000▲ 814.32% |
|---|---|
| Total Calls | 100▼ 99.58% |
| Total Puts | 1,000▼ 97.74% |
Holdings and activity of institutional investors.
| Ownership % | 26.65%▼ 58.05% |
|---|---|
| Total Invested | $3.99B▼ 65.40% |
| Investors Holding | 354▼ 384.00% |
No data